Wellington Management Group
AVBP icon

Wellington Management Group’s ArriVent BioPharma AVBP Stock Holding History

Wellington Management Group’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Sell
78,213
-4,065
-5% -$91.8K ﹤0.01% 1572
2025
Q4 		$1.66M Buy
82,278
+532
+0.7% +$11.1K ﹤0.01% 1637
2025
Q3 		$1.51M Buy
81,746
+15,417
+23% +$303K ﹤0.01% 1707
2025
Q2 		$1.44M Buy
66,329
+4,981
+8% +$103K ﹤0.01% 1652
2025
Q1 		$1.13M Buy
61,348
+19,427
+46% +$475K ﹤0.01% 1678
2024
Q4 		$1.12M Buy
+41,921
New +$1.2M ﹤0.01% 1697

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group's AVBP Position: Q1 2026 in Review

Wellington Management Group reduced its ArriVent BioPharma (AVBP) stake by 4.9% in Q1 2026, selling an estimated $91.8K and leaving 78,213 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

Wellington Management Group first reported a position in AVBP in Q4 2024 and has held it in 6 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Wellington Management Group held 78,213 shares of ArriVent BioPharma worth $1.8M as of Q1 2026.
  • Wellington Management Group sold 4,065 ArriVent BioPharma shares in Q1 2026, an estimated $91.8K.
  • ArriVent BioPharma made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1572 holding.
  • Wellington Management Group first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 6 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.